Acquiring Company
Lonza
Acquired Company
Merck KGaA CDMO business
Basel
GermanyManufacturingBiotechnologyPharmaceuticalpharmaceuticalsManufacturingBiotechnologyDescription
Merck KGaA is selling its contract development and manufacturing organisation business to Lonza for a mid-triple-digit million-euro amount. The deal includes five US facilities and about 1,100 employees, and it excludes the BioReliance testing business. The transaction is expected to close in the middle of 2027 and will be paid for in cash.
Quick answer
Lonza is acquiring Merck KGaA CDMO business, announced November 3, 2026. Lonza is based in Basel, Basel City, Switzerland.
- How much did Lonza pay for Merck KGaA CDMO business?
- The deal value was not disclosed.
- What does Lonza do?
- Lonza is a Swiss contract development and manufacturing organization (CDMO) with a focus on pharmaceutical development and manufacturing.
- Where are Lonza and Merck KGaA CDMO business based?
- Lonza is based in Basel, Basel City, Switzerland. Merck KGaA CDMO business is based in Germany.
- Who are the decision-makers at Lonza?
- Fundz holds 2 contacts at Lonza. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and pharmaceuticals
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Zeria Pharmaceutical acquires Haupt Pharma Wulfling (October 25, 2026)
- Laprophan acquires Corporate Investment Holding (October 21, 2026)
- PAI Pharma acquires Nexus Pharmaceuticals (November 12, 2026)
- Sai Parenterals acquires 60% stake in Prathyak (October 5, 2026)
- eutecma acquires Tempaid for cold chain expansion (September 28, 2026)
- Nelipak acquires Technipaq for healthcare packaging (November 11, 2026)
Who to call at Lonza, and when
When Lonza changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Lonza raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lonza, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lonza. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lonza makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Merck KGaA CDMO business?
Merck KGaA CDMO business was acquired by Lonza, based in Basel. The deal was reported on November 3, 2026. Lonza is a Swiss contract development and manufacturing organization (CDMO) with a focus on pharmaceutical development and manufacturing. Lonza is privately held and operates in Manufacturing.
When did Lonza acquire Merck KGaA CDMO business?
Lonza's acquisition of Merck KGaA CDMO business was reported on November 3, 2026. Merck KGaA is selling its contract development and manufacturing organisation business to Lonza for a mid-triple-digit million-euro amount. The deal includes five US facilities and about 1,100 employees, and it excludes the BioReliance testing business. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Merck KGaA CDMO business do?
The CDMO business is the contract development and manufacturing unit of Merck KGaA, a German group. It includes five US facilities in California, Wisconsin, Missouri and Indiana and about 1,100 employees serving biopharma companies. It is privately held, operating in Manufacturing, and is based in Germany.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.